| A scoring system for the electrostatic complementarities of T‐cell receptors and cancer‐mutant amino acids: multi‐cancer analyses of associated survival rates BI Chobrutskiy, M Yeagley, A Diviney, S Zaman, EC Gozlan, P Tipping, ... Immunology 159 (4), 373-383, 2020 | 26 | 2020 |
| A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic … DN Patel, M Yeagley, JF Arturo, S Falasiri, BI Chobrutskiy, EC Gozlan, ... International Journal of Immunogenetics 48 (5), 409-418, 2021 | 25 | 2021 |
| Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates M Hsiang, BI Chobrutskiy, M Diaz, TI Huda, S Creadore, S Zaman, ... Translational Oncology 14 (6), 101069, 2021 | 17 | 2021 |
| Electrostatic complementarity of T-cell receptor-alpha CDR3 domains and mutant amino acids is associated with better survival rates for sarcomas M Yeagley, BI Chobrutskiy, EC Gozlan, N Medikonda, DN Patel, S Falasiri, ... Pediatric Hematology and Oncology 38 (3), 251-264, 2021 | 17 | 2021 |
| Immunogenomics parameters for patient stratification in Alzheimer’s disease TI Huda, MJ Diaz, EC Gozlan, A Chobrutskiy, BI Chobrutskiy, G Blanck Journal of Alzheimer's Disease 88 (2), 619-629, 2022 | 14 | 2022 |
| Systemic adaptive immune parameters associated with neuroblastoma outcomes: the significance of gamma-delta T cells EC Gozlan, BI Chobrutskiy, S Zaman, M Yeagley, G Blanck Journal of Molecular Neuroscience, 1-12, 2021 | 9 | 2021 |
| TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates MF Arndt, DM Koohestani, BI Chobrutskiy, MM Mihyu, M Diaz, EC Gozlan, ... Human immunology 81 (12), 692-696, 2020 | 8 | 2020 |
| Specific HLA alleles, paired with TCR V-and J-gene segment usage, link to distinct multiple myeloma survival rates TI Huda, M Mihyu, EC Gozlan, MF Arndt, MJ Diaz, S Zaman, ... Leukemia & Lymphoma 62 (7), 1711-1720, 2021 | 6 | 2021 |
| Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma DB Kacsoh, MJ Diaz, EC Gozlan, A Sahoo, JJ Song, M Yeagley, ... Journal of Cancer Research and Clinical Oncology 149 (13), 12047-12056, 2023 | 2 | 2023 |
| The presence of intratumoral Porphyromonas gingivalis correlates with a previously defined pancreatic adenocarcinoma, immune cell expression phenotype and … JC Kinskey, TI Huda, EC Gozlan, JU Quach, JF Arturo, A Chobrutskiy, ... Carcinogenesis 44 (5), 411-417, 2023 | 2 | 2023 |
| Tumor resident, B-Cell receptor chemical characteristics associated with better overall survival for neuroblastoma DB Kacsoh, DN Patel, M Hsiang, EC Gozlan, A Chobrutskiy, ... Journal of Molecular Neuroscience 72 (9), 2011-2019, 2022 | 2 | 2022 |
| IGL CDR3 Hydropathy and antigen chemical complementarity associated with greater disease-free survival in lung adenocarcinoma: implications for gender disparities SV Charkowick, TI Huda, DN Patel, M Yeagley, JF Arturo, KJ Cios, ... Biochemical Genetics 62 (1), 530-546, 2024 | 1 | 2024 |
| Stratification of Wilms tumor patients using physicochemical properties of the adaptive immune receptor polypeptides, IGL and TRG DP Adams, EC Gozlan, N Medikonda, JJ Song, A Sahoo, M Yeagley, ... Journal of Pediatric Urology, 2024 | | 2024 |
| Worse Wilms’ Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs KL Rigby, MJ Diaz, EC Gozlan, DB Kacsoh, JJ Song, TR Hudock, ... Cancer Genomics & Proteomics 21 (5), 439-447, 2024 | | 2024 |
| High Level Immunoglobulin Gene Expression and Reduced Intra-tumoral Bacteria Associated With the Transition from Initial to Progressive Diffuse Intrinsic Pontine Glioma EC Gozlan, TI Huda, JU Quach, M Varkhedi, JE Desantis, G Blanck Anticancer Research 44 (6), 2325-2333, 2024 | | 2024 |
| Survival Distinctions for Cases Representing Immunologically Cold Tumors via Intrinsic Disorder Assessments for Blood-Sourced TRB Variable Regions A Sahoo, EC Gozlan, JJ Song, G Angelakakis, M Yeagley, BI Chobrutskiy, ... International Journal of Molecular Sciences 25 (21), 11691, 2024 | | 2024 |
| Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations TR Dabkowski, M Varkhedi, JJ Song, EC Gozlan, G Blanck JCO Precision Oncology 7, e2300057, 2023 | | 2023 |
| Amino acid complementarity scoring and uses thereof G Blanck, BI Chobrutskiy, TI Huda, AD Chobrutskiy, MJ Diaz, E Gozlan US Patent App. 18/174,164, 2023 | | 2023 |
| Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder … JW Waweru, KW Mwangi, VR Barker, EC Gozlan, M Yeagley, G Blanck, ... Journal of Cancer Research and Clinical Oncology 149 (8), 4359-4366, 2023 | | 2023 |
| A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding SR Mandala, AJ Thomson, EC Gozlan, DN Patel, A Chobrutskiy, ... Cancer Genomics & Proteomics 20 (3), 239-246, 2023 | | 2023 |
